CLLS

Cellectis S.A. American Depositary Shares (CLLS)

Stock · NASDAQ · Health Care

$3.4as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$2.78
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

Market cap
$270.42M
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

Cellectis S.A. American Depositary Shares Competitors

Chosen by industry and closest market cap.

  • CLLS
    Cellectis S.A. American Depositary Shares
    $3.4
    ▼ 4.36%
    Market cap $270.42MP/E
  • ELDN
    Eledon Pharmaceuticals Inc. Common Stock
    $3.19
    ▼ 3.92%
    Market cap $267.07MP/E
    $1.35$4.6
  • EBS
    Emergent BioSolutions Inc. Common Stock
    $5.91
    ▼ 0.51%
    Market cap $273.98MP/E
  • VRXA
    Veraxa Biotech AG Ordinary Shares
    $1.36
    ▼ 5.56%
    Market cap $263.02MP/E
    $1.32$27.36
  • BCYC
    Bicycle Therapeutics plc American Depositary Shares
    $4.21
    ▼ 2.77%
    Market cap $277.87MP/E
    $3.75$9.16
  • CAMP
    CAMP4 Therapeutics Corporation Common Stock
    $4.16
    ▲ 0.36%
    Market cap $282.25MP/E
    $1.41$7.75
  • ALXO
    ALX Oncology Holdings Inc. Common Stock
    $2
    ▼ 2.44%
    Market cap $283.93MP/E
    $0.96$2.66

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
10.25M
Total value held
$32.49M
Institutional holders
31
Top holders this quarter
  • Unknown3.28M
  • Unknown3.18M
  • Unknown2.74M
  • Unknown341.5K
  • Unknown226.9K
  • Unknown86.8K
  • Unknown84.3K
  • Unknown65.9K
  • Unknown44.3K
  • Unknown41.1K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.